Results 141 to 150 of about 16,063 (220)

Systematic post-translational modification genome wide identifies therapeutic targets for Alzheimer's disease: evidence from multi-cohort analysis. [PDF]

J Prev Alzheimers Dis
Wang X, Liu Y, Fu J, Li Y, Zhao M, Tian Q.   +5 more
europepmc   +1 more source

Decoding the mechanisms of amyloid-β in synaptic toxicity. [PDF]

J Alzheimers Dis
Toruński P, Pizzirusso G, Winblad B, Arroyo-García LE.   +3 more
europepmc   +1 more source

SIRT1 in the brain—connections with aging-associated disorders and lifespan [PDF]

, 2015
Fanny Ng
core   +1 more source

Cheminformatics-driven discovery of natural isoquinoline alkaloid inhibitors of Beta-secretase I for Alzheimer's management. [PDF]

PLoS One
Ahmad I, Waheed S, Alotaibi BS, Abbasi SW, Khan MU, Rahman FU, Dib H, Fawy KF, Nishan U, Ali A, Zaman A, Shah M.   +11 more
europepmc   +1 more source

Experimental and translational models of Alzheimer's disease: From neurodegeneration to novel therapeutic insights. [PDF]

J Prev Alzheimers Dis
Khan N, De S, Boddu S, Pravala N.
europepmc   +1 more source

Exploring cannabinoid modulation on autophagy mechanisms in Alzheimer's disease: a review. [PDF]

Front Pharmacol
Ntsapi C, Weyers M, Chinheya R, Jim T, Matsabisa M.   +4 more
europepmc   +1 more source

Insights into Missense SNPs on Amyloidogenic Proteins. [PDF]

Proteomes
Galanis FP, Apostolakou AE, Nasi GI, Litou ZI, Iconomidou VA.   +4 more
europepmc   +1 more source

Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Roles in Normal Physiology and Disease. [PDF]

Biomolecules
Jadhav D, Knapinska AM, Wang H, Fields GB.   +3 more
europepmc   +1 more source

Exploring molecular pathways in Alzheimer's disease neurodegeneration using biomarkers. [PDF]

Bioinformation
Mondal A, Gupta S, Bhattacharjee A, Podder A, Jani P.   +4 more
europepmc   +1 more source